PA
SEE

PharVision Advisers’s Sealed Air SEE Stock Holding History

PharVision Advisers’s Portfolio SEE Stock Details SEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,928
Closed -$277K – 778
2025
Q2 		$277K Buy
8,928
+1,622
+22% +$48.2K 0.4% 98
2025
Q1 		$211K Sell
7,306
-1,584
-18% -$51.9K 0.29% 187
2024
Q4 		$301K Buy
+8,890
New +$317K 0.25% 151

Other funds holding SEE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PharVision Advisers's SEE Position: Q3 2025 in Review

PharVision Advisers sold out of Sealed Air (SEE) in Q3 2025, closing a stake of 8,928 shares — an estimated $277K sold.

PharVision Advisers first reported a position in SEE in Q4 2024 and held it in 3 quarters. The position peaked at $301K in Q4 2024. 394 funds tracked by Wall St. Rank hold SEE as of Q3 2025.

  • PharVision Advisers reported no remaining Sealed Air position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 8,928 Sealed Air shares in Q3 2025, an estimated $277K.
  • PharVision Advisers first reported a position in Sealed Air in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Sealed Air position peaked at $301K in Q4 2024.
  • 394 funds tracked by Wall St. Rank held Sealed Air as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.